+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cynata Therapeutics - logo

Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus, using discoveries made at the University of Wisconsin-Madison (UWM). The Cymerus platform technology is based upon stem cells known as mesenchymoangioblasts (MCAs). MCAs are a precursor of mesenchymal stem (or stromal) cells (MSCs), which are at the forefront of a new generation of treatments being investigated for such devastating diseases as osteoarthritis, Crohn's disease and heart disease.

From
From
From
Stem Cell Technologies and Applications Market Report 2023-2033 - Product Thumbnail Image

Stem Cell Technologies and Applications Market Report 2023-2033

  • Report
  • November 2023
  • 337 Pages
  • Global
From
Stem Cell Therapy Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

  • Report
  • September 2023
  • 310 Pages
  • Global
From
From
Allogeneic Stem Cells - Global Strategic Business Report - Product Thumbnail Image

Allogeneic Stem Cells - Global Strategic Business Report

  • Report
  • October 2024
  • 89 Pages
  • Global
From
Stem Cell Assays - Global Strategic Business Report - Product Thumbnail Image

Stem Cell Assays - Global Strategic Business Report

  • Report
  • October 2024
  • 193 Pages
  • Global
From
Global Stem Cell Therapy Market 2024-2028 - Product Thumbnail Image

Global Stem Cell Therapy Market 2024-2028

  • Report
  • August 2024
  • 178 Pages
  • Global
From
From
From
Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024 - Product Thumbnail Image

Induced Pluripotent Stem Cell (iPSC) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator